CIK 0001082554
- Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 521984749
- Phone
- +1 301-608-9292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $344,206,005
- in 74 filings, $343.4M under 10b5-1 plans
Net −$344,206,005. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-11-28 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −800 | $485.71 | $389K | 3,330 |
| 2025-11-28 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,609 | $487.30 | $784K | 1,721 |
| 2025-11-28 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,091 | $488.36 | $533K | 630 |
| 2025-11-28 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −500 | $490.25 | $245K | 130 |
| 2025-11-28 | ROTHBLATT MARTINE A Chairperson & CEO | Exercise or conversion · Stock Option 10b5-1 | −4,000 | 58,000 | ||
| 2025-11-26 | ROTHBLATT MARTINE A Chairperson & CEO | Exercise or conversion 10b5-1 | +4,000 | $120.26 | $481K | 4,130 |
| 2025-11-26 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −2,134 | $484.45 | $1.0M | 1,996 |
| 2025-11-26 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,366 | $485.24 | $663K | 630 |
| 2025-11-26 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −500 | $487.10 | $244K | 130 |
| 2025-11-26 | ROTHBLATT MARTINE A Chairperson & CEO | Exercise or conversion · Stock Option 10b5-1 | −4,000 | 62,000 | ||
| 2025-11-26 | MAHON PAUL A EVP & GENERAL COUNSEL | Exercise or conversion 10b5-1 | +11,000 | $135.42 | $1.5M | 47,781 |
| 2025-11-26 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −513 | $483.05 | $248K | 47,268 |
| 2025-11-26 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −1,727 | $484.20 | $836K | 45,541 |
| 2025-11-26 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −2,210 | $485.15 | $1.1M | 43,331 |
| 2025-11-26 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −1,923 | $486.23 | $935K | 41,408 |
| 2025-11-26 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −3,350 | $487.21 | $1.6M | 38,058 |
| 2025-11-26 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −1,277 | $488.13 | $623K | 36,781 |
| 2025-11-26 | MAHON PAUL A EVP & GENERAL COUNSEL | Exercise or conversion · Stock Option 10b5-1 | −11,000 | 0 | ||
| 2025-11-25 | ROTHBLATT MARTINE A Chairperson & CEO | Exercise or conversion 10b5-1 | +4,000 | $120.26 | $481K | 4,130 |
| 2025-11-25 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,536 | $473.69 | $728K | 2,594 |
Page 177 of 214 · 4,273 trades